|
|
Volumn 45, Issue 1-3, 2001, Pages 159-161
|
|
Cognitive and behavioural assessment in clinical trials: When should they be done? - Discussion
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTICONVULSIVE AGENT;
CARBAMAZEPINE;
LAMOTRIGINE;
TOPIRAMATE;
BEHAVIOR;
CLINICAL TRIAL;
COGNITION;
CONFERENCE PAPER;
DRUG INDUSTRY;
DRUG SCREENING;
EPILEPSY;
HUMAN;
PRIORITY JOURNAL;
PSYCHOLOGIC ASSESSMENT;
SIDE EFFECT;
TREATMENT OUTCOME;
|
|
EID: 0034914396
PISSN: 09201211
EISSN: None
Source Type: Journal
DOI: 10.1016/S0920-1211(01)00245-5 Document Type: Conference Paper |
|
Times cited : (2)
|
|
References (5)
|
